Swiss National Bank

Bank

Position in FTRE — Fortrea Holdings Inc.

CIK 1582202 ZURICH, V8

Position in FTRE

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$3,159,840

+$1,438,806 QoQ

Shares Held

181,600

-0.6% QoQ

Ownership

0.191%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#61

of 334 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. FTRE ranks #86 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	717,440	$356,373,971
2	REGN	Regeneron Pharmaceuticals, Inc.	293,020	$182,709,690
3	ALNY	Alnylam Pharmaceuticals, Inc.	374,080	$112,609,302
4	RVMD	Revolution Medicines, Inc.	456,331	$85,461,669
5	RPRX	Royalty Pharma plc	1,159,800	$65,029,986
6	INSM	INSMED Inc	593,512	$63,280,249
7	INCY	Incyte Corp	476,874	$54,058,436
8	MRNA	Moderna, Inc.	679,900	$47,613,397

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,159,840	181,600	-0.6%	Shares	Sole	2026-08-11
2026-03-31	$1,721,034	182,700	+2.1%	Shares	Sole	2026-05-07
2025-12-31	$3,087,750	179,000	+8.4%	Shares	Sole	2026-02-12
2025-06-30	$815,692	165,120	0.0%	Shares	Sole	2025-08-12
2025-03-31	$1,246,656	165,120	-1.4%	Shares	Sole	2025-05-12
2024-12-31	$3,122,383	167,420	+1.0%	Shares	Sole	2025-02-10
2024-09-30	$3,316,400	165,820	-0.7%	Shares	Sole	2024-11-07
2024-06-30	$3,898,246	167,020	+0.5%	Shares	Sole	2024-08-08
2024-03-31	$6,672,070	166,220	0.0%	Shares	Sole	2024-05-07
2023-12-31	$5,801,078	166,220	-14.7%	Shares	Sole	2024-02-06
2023-09-30	$5,569,903	194,820	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.